urea has been researched along with dihydropyridines in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Abu Khoudoud, OR; Bikhazi, AB; Bitar, KM; el-Kasti, MM; Ibrahim, MZ; Kreydiyyeh, SI; Saleh, RS | 1 |
| Arije, A; Finomo, FO; Kadiri, S; Olatosin, AO; Salako, BL | 1 |
| Antal-Zimanyi, I; Breitenbucher, JG; Bruce, MA; Clarke, W; Higgins, MA; Martin, SW; McGovern, RT; Poindexter, GS; Romine, JL; Russell, J; Sit, SY; Ward, SA | 1 |
| Ammar, YA; Bayomi, AH; El-Sehrawi, HM; Ismail, MM; Noaman, E; Shawer, TZ | 1 |
| Chang, PT; Chen, GS; Chern, JW; Jagtap, AD; Liu, CP; Liu, JR; Tseng, HW; Wang, HC | 1 |
| Fukami, T; Inoue, M; Maeno, Y; Otsuka, M; Ozeki, T; Tagami, T | 1 |
| Guo, F; Han, X; Luan, X; Sun, X; Wang, C; Xu, L | 1 |
| Auria-Luna, F; Fernández-Moreira, V; Gimeno, MC; Herrera, RP; Marqués-López, E; Marzo, I; Romanos, E | 1 |
1 trial(s) available for urea and dihydropyridines
| Article | Year |
|---|---|
Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dihydropyridines; Disease Progression; Female; Humans; Hypertension; Lisinopril; Male; Metabolic Clearance Rate; Middle Aged; Potassium; Prospective Studies; Treatment Outcome; Urea | 2002 |
7 other study(ies) available for urea and dihydropyridines
| Article | Year |
|---|---|
Binding and distribution of three prototype calcium channel blockers in perfused rat liver.
Topics: Animals; Azides; Calcium Channel Blockers; Calcium Channels; Carbon Radioisotopes; Dihydropyridines; Inulin; Isradipine; Liver; Models, Biological; Perfusion; Rats; Rats, Sprague-Dawley; Time Factors; Tritium; Urea; Verapamil | 1997 |
Dihydropyridine neuropeptide Y Y1 receptor antagonists 2. bioisosteric urea replacements.
Topics: Caco-2 Cells; Cell Membrane Permeability; Cells, Cultured; Dihydropyridines; Drug Evaluation, Preclinical; Guanidines; Humans; Phenylurea Compounds; Receptors, Neuropeptide Y; Stereoisomerism; Structure-Activity Relationship; Urea | 2004 |
Novel pirfenidone analogues: synthesis of pyridin-2-ones for the treatment of pulmonary fibrosis.
Topics: Administration, Oral; Alanine Transaminase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspartate Aminotransferases; Bleomycin; Bronchoalveolar Lavage Fluid; Creatinine; Dihydropyridines; Disease Models, Animal; Hydroxyproline; Intubation, Intratracheal; L-Lactate Dehydrogenase; Lung; Male; Molecular Structure; Pulmonary Fibrosis; Pyridones; Rats; Time Factors; Urea | 2006 |
Bioisosteric replacement of an acylureido moiety attached to an indolin-2-one scaffold with a malonamido or a 2/4-pyridinoylamido moiety produces a selectively potent Aurora-B inhibitor.
Topics: Amides; Antineoplastic Agents; Apoptosis; Aurora Kinase B; Cell Line, Tumor; Cell Proliferation; Dihydropyridines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hep G2 Cells; Humans; Indoles; Malonates; Molecular Structure; Pyridones; Structure-Activity Relationship; Urea; Xenograft Model Antitumor Assays | 2014 |
Solid dispersions of efonidipine hydrochloride ethanolate with improved physicochemical and pharmacokinetic properties prepared with microwave treatment.
Topics: Animals; Area Under Curve; Calorimetry, Differential Scanning; Dihydropyridines; Dogs; Drug Carriers; Hot Temperature; Magnetic Resonance Spectroscopy; Male; Methylcellulose; Microwaves; Nitrophenols; Organic Chemicals; Organophosphorus Compounds; Solubility; Solvents; Urea; X-Ray Diffraction | 2016 |
Orexin-A signaling in the paraventricular nucleus modulates spontaneous firing of glucose-sensitive neurons and promotes food intake via the NPY pathway in rats.
Topics: Animals; Benzoxazoles; Dihydropyridines; Eating; Glucose; Male; Naphthyridines; Neurons; Neuropeptide Y; Orexin Receptors; Orexins; Paraventricular Hypothalamic Nucleus; Phenylurea Compounds; Proto-Oncogene Proteins c-fos; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Signal Transduction; Urea | 2018 |
Novel ureido-dihydropyridine scaffolds as theranostic agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dihydropyridines; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Structure-Activity Relationship; Urea | 2020 |